Oct 25, 2022 / 05:30PM GMT
Unidentified Participant
Hi, everyone. Welcome. I have George here from Lexaria Bioscience. And take it away.
George JurÄiÄ,Lexaria Bioscience Corp.-IR Head
Thank you very much. Thank you, everyone, for joining us today and everyone dialing in virtually. My name is George JurÄiÄ, Head of Investor Relations for Lexaria Bioscience. We do trade on the Nasdaq, LEXX; and we trade tradable warrants as well, LEXXW. We're a drug delivery platform innovator with multiple mainstream applications.
Our disclaimer slide, a lot of fun stuff in there. I'll kick off this presentation with a Lexaria Bioscience at a glance. Lexaria's DehydraTECH is a disruptive patented drug delivery technology that is more effective at delivering active pharmaceutical ingredients into the bloodstream in brain tissue. DehydraTECH is applied to multiple ingestible product format such as tablets, capsules, or suspensions, mouth melts, and more.
Pharmacokinetic or PK studies have shown to deliver more quantities of API in less time for cannabidiol
Lexaria Bioscience Corp at LD Micro Main Event Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers